BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29795309)

  • 1. Development and external validation of nomograms in oropharyngeal cancer patients with known HPV-DNA status: a European Multicentre Study (OroGrams).
    Grønhøj C; Jensen DH; Dehlendorff C; Marklund L; Wagner S; Mehanna H; Munck-Wikland E; Ramqvist T; Näsman A; Wittekindt C; Würdemann N; Sharma SJ; Gattenlöhner S; Kiss K; Andersen E; Spruce R; Batis N; Robinson M; Harrington K; Winter S; Jones TM; Klussmann JP; Dalianis T; Friborg J; von Buchwald C
    Br J Cancer; 2018 Jun; 118(12):1672-1681. PubMed ID: 29795309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk profiling based on p16 and HPV DNA more accurately predicts location of disease relapse in patients with oropharyngeal squamous cell carcinoma.
    Rasmussen JH; Grønhøj C; Håkansson K; Friborg J; Andersen E; Lelkaitis G; Klussmann JP; Wittekindt C; Wagner S; Vogelius IR; von Buchwald C
    Ann Oncol; 2019 Apr; 30(4):629-636. PubMed ID: 30657857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Externally validated HPV-based prognostic nomogram for oropharyngeal carcinoma patients yields more accurate predictions than TNM staging.
    Rios Velazquez E; Hoebers F; Aerts HJ; Rietbergen MM; Brakenhoff RH; Leemans RC; Speel EJ; Straetmans J; Kremer B; Lambin P
    Radiother Oncol; 2014 Dec; 113(3):324-30. PubMed ID: 25443497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Confirmation of the eighth edition of the AJCC/UICC TNM staging system for HPV-mediated oropharyngeal cancer in Japan.
    Mizumachi T; Homma A; Sakashita T; Kano S; Hatakeyama H; Fukuda S
    Int J Clin Oncol; 2017 Aug; 22(4):682-689. PubMed ID: 28271391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel nomograms for survival and progression in HPV+ and HPV- oropharyngeal cancer: a population-based study of 1,542 consecutive patients.
    Larsen CG; Jensen DH; Carlander AF; Kiss K; Andersen L; Olsen CH; Andersen E; Garnæs E; Cilius F; Specht L; von Buchwald C
    Oncotarget; 2016 Nov; 7(44):71761-71772. PubMed ID: 27708214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evolving landscape of human papillomavirus-related oropharyngeal squamous cell carcinoma at a single institution in Northern Italy.
    Morbini P; Alberizzi P; Ferrario G; Capello G; De Silvestri A; Pedrazzoli P; Tinelli C; Benazzo M
    Acta Otorhinolaryngol Ital; 2019 Feb; 39(1):9-17. PubMed ID: 30936574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the predictive value of OroGrams to estimate survival rates of HPV-positive oropharyngeal squamous cell carcinoma?
    Robbins J; Ali K
    Evid Based Dent; 2022 Mar; 23(1):14-15. PubMed ID: 35338318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking and papillomavirus DNA in patients with p16-positive N3 oropharyngeal squamous cell carcinoma.
    Gorphe P; Chekkoury Idrissi Y; Tao Y; Moya-Plana A; Casiraghi O; Janot F; Blanchard P; Mirghani H; Temam S
    Head Neck; 2019 Apr; 41(4):1039-1045. PubMed ID: 30552841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The applicability of new TNM classification for humanpapilloma virus-related oropharyngeal cancer in the 8th edition of the AJCC/UICC TNM staging system in Japan: A single-centre study.
    Sano D; Yabuki K; Arai Y; Tanabe T; Chiba Y; Nishimura G; Takahashi H; Yamanaka S; Oridate N
    Auris Nasus Larynx; 2018 Jun; 45(3):558-565. PubMed ID: 28760331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staging of oropharyngeal squamous cell carcinoma of the head and neck: Prognostic features and power of the 8th edition of the UICC staging manual.
    Beltz A; Gösswein D; Zimmer S; Limburg I; Wünsch D; Gribko A; Deichelbohrer M; Hagemann J; Stauber RH; Künzel J
    Eur J Surg Oncol; 2019 Jun; 45(6):1046-1053. PubMed ID: 30857877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer.
    Fakhry C; Zhang Q; Nguyen-Tân PF; Rosenthal DI; Weber RS; Lambert L; Trotti AM; Barrett WL; Thorstad WL; Jones CU; Yom SS; Wong SJ; Ridge JA; Rao SSD; Bonner JA; Vigneault E; Raben D; Kudrimoti MR; Harris J; Le QT; Gillison ML
    J Clin Oncol; 2017 Dec; 35(36):4057-4065. PubMed ID: 28777690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus association is the most important predictor for surgically treated patients with oropharyngeal cancer.
    Wagner S; Wittekindt C; Sharma SJ; Wuerdemann N; Jüttner T; Reuschenbach M; Prigge ES; von Knebel Doeberitz M; Gattenlöhner S; Burkhardt E; Pons-Kühnemann J; Klussmann JP
    Br J Cancer; 2017 Jun; 116(12):1604-1611. PubMed ID: 28472822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appraisal of the AJCC 8th edition pathologic staging modifications for HPV-positive oropharyngeal cancer, a study of the National Cancer Data Base.
    Zhan KY; Eskander A; Kang SY; Old MO; Ozer E; Agrawal AA; Carrau RL; Rocco JW; Teknos TN
    Oral Oncol; 2017 Oct; 73():152-159. PubMed ID: 28939068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review of the HPV-attributable fraction of oropharyngeal squamous cell carcinomas in Germany.
    Reuschenbach M; Tinhofer I; Wittekindt C; Wagner S; Klussmann JP
    Cancer Med; 2019 Apr; 8(4):1908-1918. PubMed ID: 30821126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of specific high-risk human papillomavirus genotypes on survival in oropharyngeal cancer.
    Garset-Zamani M; Carlander AF; Jakobsen KK; Friborg J; Kiss K; Marvig RL; Olsen C; Nielsen FC; Andersen E; Grønhøj C; von Buchwald C
    Int J Cancer; 2022 Apr; 150(7):1174-1183. PubMed ID: 34894151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Viral DNA and Promoter Hypermethylation in Salivary Rinses for Recurrent HPV-Positive Oropharyngeal Cancer.
    Shen S; Saito Y; Ren S; Liu C; Guo T; Qualliotine J; Khan Z; Sadat S; Califano JA
    Otolaryngol Head Neck Surg; 2020 Apr; 162(4):512-519. PubMed ID: 32041482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
    Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
    J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytology and direct human papillomavirus testing on fine needle aspirates from cervical lymph node metastases of patients with oropharyngeal squamous cell carcinoma or occult primary.
    Rollo F; Dona' MG; Pellini R; Pichi B; Marandino F; Covello R; Benevolo M
    Cytopathology; 2018 Oct; 29(5):449-454. PubMed ID: 29873841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nomogram for preoperative prediction of nodal extracapsular extension or positive surgical margins in oropharyngeal squamous cell carcinoma.
    Hararah MK; Stokes WA; Jones BL; Oweida A; Ding D; McDermott J; Goddard J; Karam SD
    Oral Oncol; 2018 Aug; 83():73-80. PubMed ID: 30098782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study.
    O'Sullivan B; Huang SH; Su J; Garden AS; Sturgis EM; Dahlstrom K; Lee N; Riaz N; Pei X; Koyfman SA; Adelstein D; Burkey BB; Friborg J; Kristensen CA; Gothelf AB; Hoebers F; Kremer B; Speel EJ; Bowles DW; Raben D; Karam SD; Yu E; Xu W
    Lancet Oncol; 2016 Apr; 17(4):440-451. PubMed ID: 26936027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.